- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 157
NextVPU executes series B round
Cethik-backed artificial intelligence chipmaker NextVPU has received $42.3m from unnamed investors to scale its research and development activities.
Apr 1, 2020Doctor Anywhere locates $27m
IHH Healthcare participated in a series B round that boosted the care provider's capital base to more than $40m.
Apr 1, 2020Corporate venturing deal net: 23-27 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 27, 2020Humio logs $20m series B round
Dell Technologies Capital led a $20m series B round for Humio, which will use the cash to further develop its real-time data management platform.
Mar 27, 2020Welmo swells series B round
Tepco Power Grid helped the specialised care software developer take its latest round, which already included Line, Mixi, Aioi Nissay Dowa, Akatsuki, Global Kids and Konica Minolta, to $14.3m.
Mar 27, 2020Nana puts $18m in its shopping trolley
Nana, which has seen demand for its online grocery-ordering app skyrocket in recent days, secured $18m in a series B round co-led by Saudi Technology Ventures.
Mar 27, 2020Arkose Labs authenticates $22m series B round
The anti-fraud platform developer boosted its total funding to $36m in a round led by Microsoft's M12 unit and backed by existing investor PayPal.
Mar 26, 2020Nature's Fynd unearths $80m
The Montana State University-backed edible protein developer has rebranded from Sustainable Bioproducts and received series B funding.
Mar 26, 2020Nature's Fynd unearths $80m
The edible protein developer has rebranded from Sustainable Bioproducts and received series B funding from investors including existing backers Danone and Archer Daniels Midland.
Mar 25, 2020Nurix nabs $120m
UC Berkeley's Nurix Therapeutics will use the capital to prepare two protein modulation-based immuno-oncology drugs for the clinic.
Mar 23, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


